Ultrastructural pathology of bioprosthetic heart valves with infectious endocarditis

Aim. To study the ultrastructure of mitral bioprosthetic heart valves (BHVs) which failed due to infective endocarditis.

Materials and Methods. Here we examined 7 ethylene glycol diglycidyl ether-treated xenopericardial BHVs excised during repeated BHV replacement because of prosthetic endocarditis. After being fixed in formalin and postfixed in osmium tetroxide, BHVs were dehydrated and stained in uranyl acetate with the subsequent embedding into epoxy resin, grinding, polishing, and lead citrate counterstaining. Upon the sputter coating with carbon, we visualised the BHV microanatomy by means of backscattered scanning electron microscopy at 15 kV voltage.

Results. The extracellular matrix underwent degradation and disintegration resulting in loosening, fragmentation, and reduction in the electron density of collagen and elastin fibers. We observed a number of recipient cells (macrophages, multinucleated giant cells, neutrophils, endothelial cells and smooth muscle cells) within the BHVs. The highest number of cells was localized on the valve surfaces. The localization of the recipient cells on the ventricular and atrial surfaces was different. The central part of the valves was abundantly populated by macrophages.

Conclusion. Prosthetic endocarditis is accompanied by the migration of recipient cells into the BHV structure, which is the consequence of surface and extracellular matrix disintegration.

1. Lepidi H, Casalta J-P, Fournier P-E, Habib G, Collart F, Raoul D. Quantitative Histological Examination of Bioprosthetic Heart Valves. Clin Infect Dis. 2006;42(5):590-596. https://doi.org/10.1086/500135

2. Johnston DR, Soltesz EG, Vakil N, Rajeswaran J, Rosell EE, Sabik JF, Smedira NG, Svensson LG, Lytle BW, Blackstone EH. Longterm durability of bioprosthetic aortic valves: implications from 12,569 implants. Ann Thorac Surg. 2015;99(4):1239-1247. https://doi.org/10.1016/j.athoracsur.2014.10.070

3. Kossar AP, George I, Gordon R, Ferrari G. Bacterial infiltration and bioprosthetic valve failure: Emerging diagnostics for emerging therapies. J Thorac Cardiovasc Surg. 2020;159(4):1279-1282. https://doi.org/10.1016/j.jtcvs.2019.07.149

4. Skowasch D, Steinmetz M, Nickenig G, Bauriedel G. Is the degeneration of aortic valve bioprostheses similar to that of native aortic valves? Insights into valvular pathology. Expert Rev Med Devices. 2006;3(4):453-462. https://doi.org/10.1586/17434440.3.4.453

5. Sinitsky MYu, Asanov МА, Tkhorenko BА, Odarenko YuN, Ponasenko AV. Microflora of peripheral blood obtained from patients with infective endocarditis. Russian Clinical Laboratory Diagnostics. 2018;63(10):636-640. (In Russ). https://doi.org/10.18821/0869-2084-2018-63-10-636-640

6. Butany J, Zhou T, Leong SW, Cunningham KS, Thangaroopan M, Jegatheeswaran A, Feindel C, David TE. Inflammation and infection in nine surgically explanted Medtronic Freestyle stentless aortic valves. Cardiovasc Pathol. 2007;16(5):258-267. https://doi.org/10.1016/j.carpath.2007.01.009

7. Mukhamadiyarov RA, Rutkovskaya NV, Mil’to IV, Sidorova OD, Barbarash LS. The cellular composition of explanted bioprosthetic heart valves in infective endocarditis. Arkhiv Patologii. 2019;81(6):16-23. (In Russ). https://doi.org/10.17116/patol20198106116

8. Bourguignon T, Bouquiaux-Stablo AL, Candolfi P, Mirza A, Loardi C, May MA, El-Khoury R, Marchand M, Aupart, M. Very long-term outcomes of the Carpentier-Edwards Perimount valve in aortic position. Ann Thorac Surg. 2015;99(3):831-837. https://doi.org/10.1016/j.athoracsur.2014.09.030

9. Bosio S, Leekha S, Gamb SI, Wright AJ, Terrell CL, Miller DV. Mycobacterium fortuitum prosthetic valve endocarditis: a case for the pathogenetic role of biofilms. Cardiovasc Pathol. 2012;21(4):361-364. https://doi.org/10.1016/j.carpath.2011.11.001

10. Oberbach A, Friedrich M, Lehmann S, Schlichting N, Kullnick Y, Gräber S, Buschmann T, Hagl C, Bagaev E; CardiOmics group; Clinical Microbiology group; Bioinformatics group. Bacterial infiltration in structural heart valve disease. J Thorac Cardiovasc Surg. 2019:S0022- 5223(19)30451-9. https://doi.org/10.1016/j.jtcvs.2019.02.019

11. Côté N, Pibarot P, Clavel MA. Incidence, risk factors, clinical impact, and management of bioprosthesis structural valve degeneration. Curr Opin Cardiol. 2017;32(2):123-129. https://doi.org/10.1097/HCO.0000000000000372

12. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, Miro JM, Mulder BJ, Plonska-Gosciniak E, Price S, Roos-Hesselink J, Snygg-Martin U, Thuny F, Tornos Mas P, Vilacosta I, Zamorano JL; ESC Scientific Document Group. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075-3128. https://doi.org/10.1093/eurheartj/ehv319

13. Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016;387(10021):882-893. https://doi.org/10.1016/S0140-6736(15)00067-7

14. Pibarot P, Dumesnil JG. Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation. 2009;119(7):1034- 1048. https://doi.org/10.1161/CIRCULATIONAHA.108.778886

15. Skowasch D, Schrempf S, Wernert N, Steinmetz M, Jabs A, Tuleta I, Welsch U, Preusse CJ, Likungu JA, Welz A, Lüderitz B, Bauriedel G. Cells of primarily extra-valvular origin in degenerative aortic valves and bioprostheses. Eur Heart J. 2005;26(23):2576-2580. https://doi.org/10.1093/eurheartj/ehi458